Confluence Wealth Services Inc. Buys Shares of 5,504 CME Group Inc. (NASDAQ:CME)

Confluence Wealth Services Inc. purchased a new stake in CME Group Inc. (NASDAQ:CMEGet Rating) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 5,504 shares of the financial services provider’s stock, valued at approximately $1,257,000.

Other institutional investors also recently bought and sold shares of the company. Center for Financial Planning Inc. lifted its position in CME Group by 12.9% during the 3rd quarter. Center for Financial Planning Inc. now owns 1,237 shares of the financial services provider’s stock worth $239,000 after acquiring an additional 141 shares in the last quarter. EagleClaw Capital Managment LLC lifted its position in CME Group by 5.6% during the 3rd quarter. EagleClaw Capital Managment LLC now owns 32,170 shares of the financial services provider’s stock worth $6,230,000 after acquiring an additional 1,710 shares in the last quarter. First Horizon Advisors Inc. increased its holdings in CME Group by 96.7% during the 3rd quarter. First Horizon Advisors Inc. now owns 417 shares of the financial services provider’s stock worth $69,000 after purchasing an additional 205 shares during the last quarter. Richard Bernstein Advisors LLC increased its holdings in CME Group by 14.4% during the 3rd quarter. Richard Bernstein Advisors LLC now owns 8,154 shares of the financial services provider’s stock worth $1,576,000 after purchasing an additional 1,028 shares during the last quarter. Finally, CIBC Asset Management Inc increased its holdings in CME Group by 4.3% during the 3rd quarter. CIBC Asset Management Inc now owns 67,478 shares of the financial services provider’s stock worth $13,049,000 after purchasing an additional 2,812 shares during the last quarter. Hedge funds and other institutional investors own 86.71% of the company’s stock.

Shares of CME Group stock traded down $2.61 during midday trading on Thursday, reaching $196.01. The company had a trading volume of 2,572,514 shares, compared to its average volume of 1,720,757. The stock has a fifty day moving average price of $231.36 and a 200 day moving average price of $229.64. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.01. The firm has a market cap of $70.45 billion, a PE ratio of 25.59, a P/E/G ratio of 4.34 and a beta of 0.47. CME Group Inc. has a fifty-two week low of $185.79 and a fifty-two week high of $256.94.

CME Group (NASDAQ:CMEGet Rating) last released its quarterly earnings data on Wednesday, April 27th. The financial services provider reported $2.11 EPS for the quarter, beating the consensus estimate of $2.00 by $0.11. The firm had revenue of $1.35 billion during the quarter, compared to the consensus estimate of $1.33 billion. CME Group had a return on equity of 9.29% and a net margin of 57.98%. The company’s quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.79 earnings per share. As a group, sell-side analysts forecast that CME Group Inc. will post 7.9 EPS for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, June 27th. Stockholders of record on Friday, June 10th will be given a dividend of $1.00 per share. The ex-dividend date of this dividend is Thursday, June 9th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.04%. CME Group’s dividend payout ratio is presently 52.22%.

A number of equities research analysts have recently weighed in on the company. JPMorgan Chase & Co. lowered their price target on CME Group from $202.00 to $201.00 and set a “neutral” rating for the company in a report on Thursday, February 10th. Rosenblatt Securities reduced their price target on CME Group from $268.00 to $267.00 and set a “neutral” rating for the company in a research report on Thursday, April 14th. Citigroup boosted their target price on CME Group from $275.00 to $280.00 in a research report on Thursday, April 28th. Atlantic Securities lowered CME Group from an “overweight” rating to a “neutral” rating and set a $250.00 price target on the stock. in a research report on Tuesday, February 8th. Finally, Compass Point upped their target price on CME Group from $235.00 to $250.00 and gave the stock a “neutral” rating in a research report on Thursday, February 10th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, CME Group has a consensus rating of “Hold” and a consensus target price of $254.75.

In other CME Group news, Director Daniel R. Glickman sold 750 shares of the stock in a transaction that occurred on Tuesday, March 1st. The stock was sold at an average price of $234.30, for a total value of $175,725.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Sean Tully sold 4,000 shares of the stock in a transaction that occurred on Monday, March 14th. The stock was sold at an average price of $229.80, for a total value of $919,200.00. The disclosure for this sale can be found here. Insiders have sold a total of 16,150 shares of company stock worth $3,786,944 in the last three months. 0.30% of the stock is currently owned by insiders.

CME Group Company Profile (Get Rating)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income products.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.